MARKET

QNRX

QNRX

Quoin Pharmaceuticals Ltd
NASDAQ
0.3083
-0.0227
-6.86%
After Hours: 0.3127 +0.0044 +1.43% 19:45 02/14 EST
OPEN
0.3300
PREV CLOSE
0.3310
HIGH
0.3346
LOW
0.3022
VOLUME
986.88K
TURNOVER
--
52 WEEK HIGH
6.18
52 WEEK LOW
0.2811
MARKET CAP
2.52M
P/E (TTM)
-0.0464
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at QNRX last week (0203-0207)?
Weekly Report · 5d ago
Quoin Pharmaceuticals launches ‘NETHERTON NOW’ campaign
TipRanks · 02/04 12:37
Quoin Pharmaceuticals Launches ‘NETHERTON NOW’ Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure
Barchart · 02/04 06:30
Weekly Report: what happened at QNRX last week (0127-0131)?
Weekly Report · 02/03 12:19
Weekly Report: what happened at QNRX last week (0120-0124)?
Weekly Report · 01/27 12:23
Quoin Pharmaceuticals: Buy Rating Affirmed Amidst Potential First-Mover Advantage in Netherton Syndrome Treatment
TipRanks · 01/24 16:15
Quoin Pharmaceuticals Shares New Insights On QRX003's Efficacy In Netherton Syndrome
NASDAQ · 01/23 16:46
Quoin Pharmaceuticals announces further clinical evidence on QRX003 efficacy
TipRanks · 01/23 13:46
More
About QNRX
Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.

Webull offers Quoin Pharmaceuticals Ltd - ADR stock information, including NASDAQ: QNRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QNRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QNRX stock methods without spending real money on the virtual paper trading platform.